NCT03142425View on ClinicalTrials.gov

Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy

UnknownOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

June 19, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Radiation Therapy
Trial Locations (2)

90027

RECRUITING

Kaiser Permanente Los Angeles Medical Group, Los Angeles

91010

RECRUITING

City of Hope, Duarte

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

DxTerity Diagnostics

INDUSTRY

NCT03142425 - Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy | Biotech Hunter | Biotech Hunter